Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Lancet Oncol. 2014 Jan 16;15(2):156–163. doi: 10.1016/S1470-2045(13)70589-8

Figure 3.

Figure 3

Hazard ratios and confidence intervals for all patients and for patients with known ER status of the primary tumour: Disease-free survival (DFS, A) and overall survival (OS, B) for all 162 patients together and according to the ER status of the isolated locoregional recurrence (ILRR); DFS for 143 patients who had ER status available for both primary tumour and ILRR (C). The size of the boxes is proportional to the number of events. The x-axis is on a log scale.